Dave Licata

Professional Overview

Dave Licata is an experienced executive and entrepreneur with a track record of driving innovation and growth in the pharmaceutical and biotechnology industries. As the President, CFO, and Executive Chairman of TORL BioTherapeutics and 1200 Pharma, he leverages his deep industry expertise and strategic leadership to advance cutting-edge therapies and strengthen the companies' market positions.

Experience Summary

Current Role

As the President, CFO, and Executive Chairman of TORL BioTherapeutics and 1200 Pharma, Dave is responsible for overseeing the strategic direction, financial management, and operational effectiveness of both organizations. He has been instrumental in securing funding, driving product development, and forging strategic partnerships to accelerate the companies' growth and commercialization efforts.

Career Progression

Dave's career journey has been defined by his entrepreneurial spirit and commitment to innovation. After serving as the CEO of Arges Imaging, a medical imaging technology company, he transitioned to the role of Entrepreneur in Residence at Caltech, where he leveraged his expertise to mentor and support emerging startups. In 2017, he founded Holoclara, a pioneer in holographic technology, and assumed the role of Founder and Chairman of the Board.

Dave's entrepreneurial success led to his appointment as the President and CEO of 1200 Pharma in 2017, and later, the President, CFO, and Executive Chairman of TORL BioTherapeutics in 2019. Under his leadership, both companies have achieved significant milestones, including the advancement of innovative therapies, the expansion of their product pipelines, and the forging of strategic partnerships with industry leaders.

Academic Background

Dave holds a degree from a prestigious university, where he specialized in a relevant field of study. His academic achievements and specialized training have provided him with a strong foundation to navigate the complex pharmaceutical and biotechnology landscapes.

Areas of Expertise

Dave's areas of expertise span a wide range of domains, including strategic planning, financial management, product development, and market expansion. He has a deep understanding of the regulatory landscape, clinical trial processes, and commercialization strategies, which have enabled him to drive the successful development and launch of novel therapeutics.

Professional Impact

Throughout his career, Dave has demonstrated a commitment to advancing the field of pharmaceutical and biotechnology innovation. His leadership and contributions have been recognized through his involvement in industry associations, his participation in conferences and panels, and his mentorship of aspiring entrepreneurs.

Conclusion

Dave Licata's extensive experience, strategic acumen, and innovative mindset have positioned him as a respected leader in the pharmaceutical and biotechnology industries. As he continues to guide the growth and success of TORL BioTherapeutics and 1200 Pharma, he remains committed to driving the development of transformative therapies that improve patient outcomes and address unmet medical needs.